Skip to main content

Mark Cuban Launches Digital Pharmacy, Promises Cost Transparency

by Nadia El-Yaouti | Feb 02, 2022
Mark Cuban smiling while seated at an event, accompanied by another individual.
Photo Source: Dallas Mavericks owner Mark Cuban looks on from the crowd during NBA All-Star Saturday in Los Angeles, file photo, Feb. 17, 2018. (AP Photo/Chris Pizzello, File)

Billionaire businessman Mark Cuban is focusing his philanthropic efforts on his latest venture, an online pharmacy that will offer generic drugs at affordable prices to consumers.

Cuban announced the launch of his online pharmacy last week, and unlike traditional distributors, Cuban’s pharmacy has been overly transparent in what the costs to consumers will be.

The online pharmacy costplusdrugs.com explains, "We started Mark Cuban Cost Plus Drug Company because every American should have access to safe, affordable medicines. If you don’t have insurance or have a high deductible plan, you know that even the most basic medications can cost a fortune. Many people are spending crazy amounts of money each month just to stay healthy. No American should have to suffer or worse—because they can't afford basic prescription medications."

The digital pharmacy explains that it will sell generic forms of medication at their cost price with a 15% markup. Industry sources detail that some drug distributors can mark up the price of drugs anywhere from 25% to over 100%. Cuban’s online pharmacy promises to keep costs low by staying consistent with its 15% markup. There will also be a $3 pharmacist fee and a shipping fee for an additional $5.

Efforts to keep generic drug costs low stem from the recent scandals of price gouging including that of “Pharma Bro” Martin Shkreli. Shkreli made national headlines after hiking up the price of the antiparasitic drug Daraprim from $13.50 a pill to a whopping $750 per pill. He has since been arrested and is serving time in a Pennsylvania prison over securities fraud.

In an email with Forbes news, Cuban explains his rationale for his low-cost pharmacy: “It's ridiculous what the pricing for generic drugs is. Period end of story.” One of the first drugs offered on the digital Pharmacy will be a drug used to treat a parasitic hookworm. The drug albendazole retails for an average price of $225 per pill. In Cuban’s pharmacy, it will cost $20 per pill. Cuban also shares the example of the drug Imatinib, a chemotherapy drug used by patients with leukemia. The drug retails at $9,657 per month and $120 a month with the use of a voucher. Cuban’s pharmacy will sell the generic for the low cost of $47 per month.

While the online pharmacy is branded by the billionaire’s iconic name, Dr. Alex Oshmyansky is the CEO and founder of the billionaire-backed philanthropic venture. Oshmyansky reached out to Cuban via email and the pair decided to move forward with plans for a digital pharmacy that would give millions of Americans access to affordable generic medication. Oshmyansky detailed his frustration over price hiking for necessary drugs and explained, “I had patients have serious injuries from the high cost of drugs, which should have been very cheap. I've been angry about it for a long time.”

The digital pharmacy will begin selling drugs used to treat an array of conditions including HIV, diabetes, cancer medications, and more. In response to adding additional medications to the digital marketplace, Cuban explained through a tweet “We will add them as quickly as we can.” He adds that the company has plans to build a facility in Dallas to provide their “own injectables as well.”

Share This Article

If you found this article insightful, consider sharing it with your network.

Nadia El-Yaouti
Nadia El-Yaouti is a postgraduate from James Madison University, where she studied English and Education. Residing in Central Virginia with her husband and two young daughters, she balances her workaholic tendencies with a passion for travel, exploring the world with her family.

Related Articles

CVS Health logo displayed on the glass facade of a modern office building.

CVS Health to Split in Two, Separating Aetna and Caremark From 9,000 Pharmacies

CVS Health announced Wednesday, November 4, 2026, that it plans to split into two publicly traded companies, separating its Aetna health insurance and Caremark prescription drug businesses from approximately 9,000 retail pharmacies. The breakup would unwind a nearly decade-old strategy of combining insurance, drug benefits and pharmacy services under one... Read More about CVS Health to Split in Two, Separating Aetna and Caremark From 9,000 Pharmacies

Pharmacy worker holds a blister pack of blue-and-white capsules while reaching for a medication box on a pharmacy shelf.

Trump Administration Orders Drug Middlemen to Reveal Fees and Profits

The Trump administration finalized a federal rule Thursday requiring pharmacy benefit managers to reveal how much money they collect from drugmakers, pharmacies and employer health plans, including rebates, fees and profits tied to prescription drug pricing arrangements. The new requirements also give large self-insured health plans the right to independently... Read More about Trump Administration Orders Drug Middlemen to Reveal Fees and Profits

Gloved medical professional holds an intravenous drug infusion bag in a clinical setting.

Drugmakers Sue to Block Trump Medicare Plan Tying Drug Costs to Lower Foreign Prices

The pharmaceutical industry’s leading trade group is suing the Trump administration over a new Medicare drug-pricing program that could lower out-of-pocket costs for some patients receiving expensive cancer, autoimmune, and other medications administered in medical settings.The Pharmaceutical Research and Manufacturers of America, or PhRMA, filed the lawsuit on October 7,... Read More about Drugmakers Sue to Block Trump Medicare Plan Tying Drug Costs to Lower Foreign Prices

Martin Shkreli leaving a courthouse surrounded by people and media.

Federal Judge Rules Martin Shkreli to Pay $64.6 Million in Fines and Receive a Lifetime Ban From Working in the Pharmaceutical Industry

Imprisoned Martin Shkreli, aka “Pharma Boy,” is now facing a ruling by a federal judge that orders him to be banned “for life” from the drug industry plus pay fines of $64.6 million to seven states. The order follows the infamous trial where then-CEO Shkreli and company Vyera Pharmaceuticals were... Read More about Federal Judge Rules Martin Shkreli to Pay $64.6 Million in Fines and Receive a Lifetime Ban From Working in the Pharmaceutical Industry

Legal term

Search articles and Legalpedia

Subscribe to Newsletter